Journal: Molecular Metabolism
Article Title: NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition
doi: 10.1016/j.molmet.2022.101626
Figure Lengend Snippet: NIK inhibits GH-induced STAT5 activation via JAK2S633 phosphorylation . A) Western blot analysis of pSTAT5, STAT5 and β-ACTIN levels in primary hepatocytes isolated from NIK fl/fl and NIK LKO mice after ex vivo stimulation with GH. B) Western blot analysis of pSTAT5, STAT5 and β-ACTIN levels in primary hepatocytes isolated from NIK fl/fl and NIK LKO mice after ex vivo double stimulation with GH and TWEAK and the respective quantification (n = 3). C) NIKTΔ3 construct used in ex vivo studies. After HTNC-mediated deletion of the loxP-flanked STOP cassette, NIKTΔ3 is expressed under control of the ROSA26 promoter. D) For Co-IP R26- NIKΔT3 fl and NIKΔT3 MEFs were treated with GH for 0 min or 15 min. Cell extracts were co-immunoprecipitated (IP) with an α -Flag antibody and immunoblotted with JAK2 (n = 3) and STAT5. E) Western blot analysis of pJAK2, JAK2 and β-ACTIN levels in liver tissue NASH-fed NIK fl/fl and NIK LKO mice (n = 3/3). F) Western blot analysis of pJAK2, JAK2 and β-ACTIN levels in liver tissue from CDAA-fed NIK fl/fl and NIK LKO mice (n = 3/3) G) Western blot analysis of pJAK2, JAK2 and β-ACTIN levels in non-tumor liver tissue from DEN-injected NIK fl/fl and NIK LKO mice (n = 3/3). H) JAK2 domain structure (human). Positive regulatory phosphorylation sites are labeled green. Negative inhibitory phosphorylation sites are marked in red. FERM: FERM domain, PK: pseudokinase, TK: tyrosine kinase. Single letter amino acid sequence of NIK binding motif in IKK1 and the predicted binding motif in JAK2. Box indicates conserved amino acids. I) Western blot analysis of pSTAT5, STAT5 and β-ACTIN levels in NIK fl/fl and NIK KO MEF transfected with either pCMV- JAK2wt or with pCMV- JAK2S633A and treated with GH for the indicated timepoints (n = 3). Data are presented as mean ± SEM; ∗p ≤ 0.05, ∗∗p ≤ 0.01, versus control. Statistical analyses were performed using Student's t -test.
Article Snippet: Human Commercial cDNA Array NIK mRNA levels were analyzed in a commercial cDNA array (origene, #LVRT101) prepared from hepatocarcinoma (Grade 1-3) and healthy human liver tissues.
Techniques: Activation Assay, Phospho-proteomics, Western Blot, Isolation, Ex Vivo, Construct, Control, Co-Immunoprecipitation Assay, Immunoprecipitation, Injection, Labeling, Sequencing, Binding Assay, Transfection